MP62-19 RISK STRATIFICATION DETERMINED BY DURATION OF ANDROGEN DEPRIVATION THERAPY, SERUM ALKALINE PHOSPHATASE, AND HEMOGLOBIN LEVEL PREDICTS OVERALL SURVIVAL IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI